Every record from Janoshik · page 11
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042700 | Semaglutide | GGPeps | GGPE-2604-L9412 | 2026-Q2 | 99.21 | 5.68 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042626 | BPC-157 | GGPeps | GGPE-2602-E8672 | 2026-Q2 | 98.63 | 4.81 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042570 | GHK-Cu | ERP | ERP-2604-K8139 | 2026-Q2 | 98.02 | 6.43 | 96.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042438 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 97.94 | 3.70 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2026-041662 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.38 | 3.71 | 106.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041433 | BPC-157 | QYB | QYB-2601-D4733 | 2026-Q2 | 99.93 | 3.66 | 91.4 | Supplier-supplied | 0 | PASS |
| AX-2026-041270 | Epitalon | WWB | WWB-2602-G2822 | 2026-Q2 | 99.75 | 6.69 | 88.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043004 | Tirzepatide | KP | KP-2602-X5446 | 2026-Q2 | 98.71 | 6.71 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042578 | SLU-PP-332 | GGPeps | GGPE-2511-R8569 | 2026-Q2 | 98.31 | 4.42 | 101.5 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041699 | Semaglutide | QSC | QSC-2604-H9231 | 2026-Q2 | 99.23 | 6.32 | 98.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043216 | SLU-PP-332 | SGN | SGN-2602-X9969 | 2026-Q2 | 98.00 | 6.32 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042970 | 5-Amino-1MQ | KP | KP-2511-W4792 | 2026-Q2 | 98.89 | 4.03 | 91.0 | Supplier-supplied | 2 | FAIL |
| AX-2026-042859 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 98.21 | 4.30 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042588 | SLU-PP-332 | GGPeps | GGPE-2511-R8569 | 2026-Q2 | 99.25 | 4.28 | 88.7 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042554 | GHK-Cu | ERP | ERP-2601-F7633 | 2026-Q2 | 98.45 | 4.56 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042440 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 97.88 | 4.00 | 98.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042360 | Sermorelin | HJ | HJ-2605-A4196 | 2026-Q2 | 98.86 | 5.73 | 90.6 | Supplier-supplied | 0 | PASS |
| AX-2026-041700 | Semaglutide | QSC | QSC-2604-H9231 | 2026-Q2 | 98.79 | 6.57 | 103.1 | Supplier-supplied | 2 | FAIL |
| AX-2026-042858 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 98.06 | 4.29 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042764 | BPC-157 | GGPeps | GGPE-2605-B9821 | 2026-Q2 | 98.76 | 4.99 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042320 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 99.05 | 4.88 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042100 | Retatrutide | TFC | TFC-2512-G7985 | 2026-Q2 | 98.44 | 1.97 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-041619 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.59 | 104.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041392 | Adipotide | WWB | WWB-2512-R4093 | 2026-Q2 | 98.74 | 2.54 | 89.2 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043445 | Semaglutide | WXT | WXT-2512-F4804 | 2026-Q2 | 98.96 | 4.62 | 94.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043253 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.42 | 5.39 | 94.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043237 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 98.73 | 2.19 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043152 | MOTS-c | SSA | SSA-2511-W7415 | 2026-Q2 | 98.64 | 5.48 | 88.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043188 | L-Carnosine | GL Biochem | GLBI-2512-S8438 | 2026-Q2 | 98.77 | 9.21 | 91.9 | Supplier-supplied | 2 | FAIL |
| AX-2026-042906 | Semax | MKM | MKM-2512-B2992 | 2026-Q2 | 98.43 | 6.67 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042272 | Liraglutide | Homopeptide | HOMO-2602-E2761 | 2026-Q2 | 99.93 | 3.91 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043388 | Melanotan II | CPC | CPC-2605-U3868 | 2026-Q2 | 98.96 | 3.53 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043374 | BPC-157 | CPC | CPC-2601-M2514 | 2026-Q2 | 98.73 | 6.46 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042969 | 5-Amino-1MQ | KP | KP-2511-W4792 | 2026-Q2 | 99.33 | 3.94 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-042518 | Liraglutide | ERP | ERP-2601-P6802 | 2026-Q2 | 98.47 | 4.05 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042235 | N-Acetyl Semax Amide | Homopeptide | HOMO-2603-C1382 | 2026-Q2 | 99.22 | 8.28 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042154 | Tirzepatide | Homopeptide | HOMO-2601-N9196 | 2026-Q2 | 98.99 | 5.10 | 106.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042113 | PT-141 (Bremelanotide) | TFC | TFC-2512-M8211 | 2026-Q2 | 99.13 | 7.10 | 98.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041953 | MOTS-c | TFC | TFC-2605-R4770 | 2026-Q2 | 99.72 | 5.27 | 90.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-041671 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.31 | 4.07 | 91.0 | Supplier-supplied | 1 | MARGINAL |